| Optimizing pharmacokinetics/pharmacodynamics of β-lactam/β-lactamase inhibitor combinations against high inocula of ESBL-producing bacteria VH Tam, H Abodakpi, W Wang, KR Ledesma, PR Merlau, K Chan, ... Journal of Antimicrobial Chemotherapy 76 (1), 179-183, 2021 | 20 | 2021 |
| Characterization of amikacin drug exposure and nephrotoxicity in an animal model K Chan, KR Ledesma, W Wang, VH Tam Antimicrobial Agents and Chemotherapy 64 (9), 10.1128/aac. 00859-20, 2020 | 18 | 2020 |
| Prevalence of extended-spectrum beta-lactamase and carbapenemase-producing bloodstream isolates of Klebsiella pneumoniae in a tertiary care hospital H Abodakpi, KT Chang, AM Sánchez Díaz, R Cantón, TM Lasco, K Chan, ... Journal of Chemotherapy 30 (2), 115-119, 2018 | 14 | 2018 |
| A robust LC–MS/MS method for amikacin: application to cellular uptake and pharmacokinetic studies K Chan, W Wang, KR Ledesma, T Yin, VH Tam Bioanalysis 12 (7), 445-454, 2020 | 13 | 2020 |
| Current epigenetic insights in kidney development K Chan, X Li Genes 12 (8), 1281, 2021 | 12 | 2021 |
| Local tissue response to subcutaneous administration of ceftriaxone in an animal model VH Tam, DN Cohen, KR Ledesma, B Guillory, K Chan, KW Garey Antimicrobial Agents and Chemotherapy 64 (3), 10.1128/aac. 02090-19, 2020 | 4 | 2020 |
| The Role of Megalin in Aminoglycoside-Associated Toxicity in the Kidney K Chan | | 2021 |
| AMIKACIN DOSE-DEPENDENT ONSET OF NEPHROTOXICITY IN RATS. K Chan, K Ledesma, W Wang, V Tam CLINICAL PHARMACOLOGY & THERAPEUTICS 107, S61-S61, 2020 | | 2020 |
| Fitting Fisher's Geometric Model to Mutation Accumulation Experimental Data Using Approximate Bayesian Computation K Chan University of Houston, 2014 | | 2014 |
